This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
Recognising the true impact of UC on a patient’s quality of life and timely identification of when their disease may be uncontrolled can be a challenge in regular practice, particularly if there is limited time with the patient. Here are some practical resources to help you have deeper conversations with your patients to bridge this gap to help them get back to their baseline.
These tools are designed to help establish preferences for treatment options from your patients, as well as their expectations and aspirations for treatment goals. By adopting a shared decision-making approach, aided by deeper conversations between each patient and their doctor, we can strive to prevent patients with UC from having to settle for being just “OK”.
This resource can help you uncover the full burden of your patients’ UC and align on care goals through early and effective dialogue
Click here for Xeljanz®(tofacitinib citrate) Prescribing information and click here for VELSIPITY▼ (etrasimod) Prescribing Information.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2025 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024.